CSBR / Champions Oncology, Inc. - Net Long/Short Value

Champions Oncology, Inc.
US ˙ NasdaqCM ˙ US15870P3073

CSBR / Champions Oncology, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
HighTower Advisors, LLC
BlackRock, Inc.
Tocqueville Asset Management L.p.
NEA Management Company, LLC
SBI Securities Co., Ltd.
Dimensional Fund Advisors Lp
Battery Management Corp.
Bank Of America Corp /de/
Mesirow Financial Investment Management, Inc.
Vanguard Global Advisers, LLC
Bank of New York Mellon Corp
Essex Investment Management Co Llc
Mink Brook Asset Management LLC
Capital Advisors, Ltd. LLC
Vanguard Group Inc
Morgan Stanley
Geode Capital Management, Llc
Northern Trust Corp
Acadian Asset Management Llc
Vanguard Fiduciary Trust Co
Cambridge Investment Research Advisors, Inc.
State Street Corp
Jane Street Group, Llc
Cassaday & Co Wealth Management LLC
Renaissance Technologies Llc
Vanguard Capital Management Llc
Jpmorgan Chase & Co
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:2I3 4,88 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista